🏛️ Verified NIH Record • Updated 2026-08-13
Investigations of Reproductive Cancers in Women (NCT06527157)
PROspective ACcrual To Investigate reprOductive Cancers in womeN
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: PinkDx, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding.
Who can join: Review the eligibility criteria below.
Location: University of Alabama, Birmingham — Birmingham, Alabama
Age range: 45 Years to 100 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (16 Sites)
- University of Alabama, Birmingham — Birmingham, Alabama
- Sutter Health — San Carlos, California
- Advent Health Orlando — Orlando, Florida
- Ob-Gyne Associates of Lake Forest, Ltd — Lake Forest, Illinois
- Indiana University, Eskenazi Health — Indianapolis, Indiana
- Mayo Clinic — Rochester, Minnesota
- Washington University School of Medicine — St Louis, Missouri
- Columbia University — New York, New York
- Summa Health — Akron, Ohio
- The Ohio State University — Columbus, Ohio
- Avera Research Institute — Sioux Falls, South Dakota
- University of Tennessee Health Science Center — Memphis, Tennessee
- Meharry Medical College — Nashville, Tennessee
- Baylor College of Medicine/Texas Children's Hospital — Houston, Texas
- Houston Methodist — Houston, Texas
- University of Texas Health Science Center at San Antonio — San Antonio, Texas
📞 Contact the Study Coordinator
Phone: (463) 273-7024
Email: devon@pinkdx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Uterine Cancer
- AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma — Boston, Massachusetts
- Insights Into Participating in Studies for Uterine Cancer — San Francisco, California
- Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer — San Francisco, California
- [18F]FES PET/.CT in Uterine Cancer — Philadelphia, Pennsylvania
- Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking — Durham, North Carolina
Explore by condition: All Uterine Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.